ALK and neuroblastoma: Anaplastic Lymphoma Kinase (ALK) was upregulated in advanced/metastatic neuroblastomas [14,15], and furthermore, treatment of ALK-positive neuroblastoma cells with tunicamycin, an inhibitor of N-glycosylation, impaired the pro-survival signaling pathway [16].